Snu Rdb Foundation

Other

Seoul National University

Amorepacific Corporation

Shin Poong Pharmaceutical Co., Ltd.

Jungjinho Effect Inc.

Jin Ho Chung

Yeon Kyung Kim

Young Mee Lee

So Min Kang

Jin Yong Kim

Jae Young Lee

Dong Hun Lee

Seung Woo Noh

Sung Won Park

Dong Won Lee

Tae Ryong Lee

Hee Chan Kim

Jei Man Ryu

Sungwan Kim

Min Jung Lee

Hyun Jung Choi

Jeong Hill Park

Youdan Kim

Chi Yul Yoon

Hyeon Chung Kim

Seung Ki Lee

Eui Dong Son

Eun Ju Kim

Oh Sang Kwon

Man Ki Park

Geum Sil Cho

Gae Won Nam

Seon Pil Jin

Bok Deuk Kim

Jin Hun Park

Hyoung Woo Lim

June Hyunkyung Lee

Kang Hyeok Lee

Se Rah Lee

Woo Ile Park

Jeong-eun Shin

Serah Lee

Ji-Yong Jung

Jang Hee Oh

Woo Seok Koh

Eun Young Seo

Hyun Sun Yoon

Inn Gyung Oh

Jeiman Ryu

Ji Hyun Kim

Chi Hyun Park

The present invention relates to a composition comprising adiponectin-derived peptide fragments and, more specifically, to a cosmetic composition and pharmaceutical composition for promoting hair growth comprising, as an active ingredient, one or more adiponectin-derived peptides selected from the group consisting of amino acid sequences of SEQ ID NOS: 1 to 21. The adiponectin-derived peptides activate the cell division of dermal papilla cells and outer root sheath cells of hair follicles, promote hair growth in the hair follicles, and also increase the expression of hair growth factors in the dermal papilla cells, and thus a composition of the present invention comprising the adiponectin-derived peptides can be effectively used to promote hair growth and inhibit hair loss.

Composition for promoting hair growth comprising adiponectin-derived peptide

The present invention relates to a novel compound having an effect of inhibiting platelet aggregation and a salt thereof and, more specifically, to: a novel platelet aggregation inhibitor specifically inhibiting shear stress-induced platelet aggregation; a pharmaceutical composition containing the same as an active ingredient; and a preparation method therefor.

Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same

TRPV1 inhibitory peptides and a composition for skin-aging prevention and wrinkle improvement comprising the same as an active ingredient are described. The TRPV1 inhibitory peptide of the present subject matter inhibits the expressions of MMP and proinflammatory cytokines induced by UV exposure and reduces skinfold thickness and intracellular Cainflux, so that it can be effectively used as an active ingredient of the composition for skin-aging prevention, wrinkle improvement, skin-whitening, or alleviating inflammation, irritation, or pain.

TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same

Provided is a system and method for evaluating laser treatment, for converting the attribute of a laser beam and numerically evaluating proficiency of a laser treatment operator by processing data obtained by photographing the converted laser beam so as to use the evaluated data as training data. The laser treatment evaluating system includes an attenuation unit for attenuating intensity of a laser beam transmitted through a transmissive plate, a camera for photographing the laser beam transmitted through the attenuation unit, and an image data processing apparatus connected to the camera, for processing an image captured by the camera, tracking a trajectory of a laser beam on the transmissive plate, and calculating a distribution state of spots on which the laser beam on the transmissive plate is emitted.

System and method for evaluating laser treatment

The present invention relates to a method for calculating a thermal protection factor, wherein the method comprises the steps of: applying heat to a first area coated with a thermal protection material, and a second area not coated with the thermal protection material; measuring the respective saturation temperatures of the first area and second area; calculating a first energy by dividing the energy corresponding to the heat applied to the first area by the saturation temperature of the first area; calculating a second energy by dividing the energy corresponding to the heat applied to the second area by the saturation temperature of the second area; and calculating the thermal protection factor of a thermal protection material by dividing the first energy by the second energy or dividing the difference between the first energy and the second energy by the first energy.

Method for calculating a thermal protection factor

TRPV1 inhibitory peptide and a composition thereof for skin-aging prevention, wrinkle improvement, skin-whitening, or alleviating inflammation, irritation or pain is described, where the TRPV1 inhibitory peptide inhibits the expressions of MMP and proinflammatory cytokines induced by UV exposure and reduces skinfold thickness and intracellular Cainflux.

The present invention relates to a composition for improving inflammatory disease, and more specifically to a composition for improving inflammatory disease able to improve inflammatory reactions and the barrier function of epithelial tissue such as the skin, to enhance aging resistance and skin elasticity and to prevent or treat aging. The present invention makes it possible to control inflammatory reactions by modulating the expression and modulating the activity of ABH antigens, and thus the composition of the present invention can be employed as a development marker for therapeutic agents designed to soothe or treat or help in the treatment of disease caused by inflammatory reaction in body tissue and notably the skin expressed by ABH antigens, and can be used in the development of external preparations and cosmetics containing external preparations designed for the purposes such as restoration of normal function and moisturization, wrinkle enhancement, whitening and elasticity recovery in skin through modulation of differentiation of keratinocytes and the skin barrier function.

Composition for improving inflammatory disease using ABH antigens

Disclosed are bovine excretion extracts having anticancer and anti-inflammatory activity prepared by a process comprising the step of extracting bovine excretion with a polar solvent selected from the group consisting of lower alcohol, lower ketone, acetonitrile, water and mixtures thereof, a process for preparing the same, and the use thereof as an anticancer agent or adjuvant, or an anti-inflammatory agent.

Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same

Growing community of inventors

Seoul, South Korea

Jin Ho Chung